DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Hydrocortisone (Hydrocortisone Topical) - Abdominal Pain - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Abdominal Pain (20)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Hydrocortisone (Hydrocortisone Topical) where reactions include abdominal pain. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Hydrocortisone side effects in

Reported by a physician from United States on 2012-08-22

Patient:

Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Coagulopathy, Hypoglycaemia, Hypocalcaemia, Hypoxia, Hiccups, Alanine Aminotransferase Abnormal, Pneumonitis, Cough, Pain in Extremity, Hypotension, Hyperglycaemia, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Methotrexate Sodium
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin HCL
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Vancomycin; Posaconazole; Voriconazole; Levofloxacin



Possible Hydrocortisone side effects in

Reported by a physician from United States on 2012-08-20

Patient:

Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypokalaemia, Blood Bilirubin Abnormal, Hiccups, Pleural Effusion, Hypoxia, Hypocalcaemia, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Decreased Appetite, Pain in Extremity, Hypotension, Hyperglycaemia, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, External Ear Pain, Hypercalcaemia, Haematotoxicity, Hypophosphataemia, Diarrhoea, Dehydration, Hypoalbuminaemia, Lower Gastrointestinal Haemorrhage, Hypertension, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Levofloxacin; Voriconazole; Posaconazole; Vancomycin



Possible Hydrocortisone side effects in

Reported by a physician from United States on 2012-08-14

Patient:

Reactions: Thrombosis, Abdominal Pain, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypoxia, Hypocalcaemia, Hiccups, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Pain in Extremity, Hyperglycaemia, Hypotension, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Neuropathy Peripheral, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Hyponatraemia, Gamma-Glutamyltransferase Abnormal, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Levofloxacin; Vancomycin; Posaconazole; Voriconazole



Possible Hydrocortisone side effects in

Reported by a physician from United Kingdom on 2012-07-17

Patient:

Reactions: Abdominal Pain, Tachycardia, Skin Toxicity, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Dizziness, Oedema, Hallucination, Vomiting, Nausea, Gastrointestinal Toxicity, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Condition Aggravated, Adult T-Cell Lymphoma / Leukaemia, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction

Adverse event resulted in: death

Drug(s) suspected as cause:
Hydrocortisone
    Indication: Adult T-Cell Lymphoma / Leukaemia

Doxorubicin HCL
    Dosage: on day 1 of 21 day, (cycle 1-5)

Cytarabine
    Indication: Adult T-Cell Lymphoma / Leukaemia

Cyclophosphamide
    Dosage: on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Zenapax
    Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
    Indication: Adult T-Cell Lymphoma / Leukaemia

Vincristine
    Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Prednisolone
    Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia

Methotrexate
    Indication: Adult T-Cell Lymphoma / Leukaemia

Radiotherapy
    Indication: Adult T-Cell Lymphoma / Leukaemia

Doxorubicin HCL
    Dosage: on day 1 of 21 day, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Other drugs received by patient: Acyclovir; Thiabendazole; Cotrim; Itraconazole



Possible Hydrocortisone side effects in

Reported by a physician from United Kingdom on 2012-07-10

Patient:

Reactions: Abdominal Pain, Skin Toxicity, Tachycardia, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Oedema, Dizziness, Hallucination, Vomiting, Gastrointestinal Toxicity, Nausea, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Adult T-Cell Lymphoma / Leukaemia, Condition Aggravated, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Prednisolone
    Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia

Cytarabine
    Indication: Adult T-Cell Lymphoma / Leukaemia

Doxorubicin HCL
    Dosage: on day 1 of 21 day, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Vincristine
    Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Methotrexate
    Indication: Adult T-Cell Lymphoma / Leukaemia

Zenapax
    Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
    Indication: Adult T-Cell Lymphoma / Leukaemia

Hydrocortisone
    Indication: Adult T-Cell Lymphoma / Leukaemia

Radiotherapy
    Indication: Adult T-Cell Lymphoma / Leukaemia

Other drugs received by patient: Cotrim; Itraconazole; Thiabendazole; Acyclovir



Possible Hydrocortisone side effects in 10 year old female

Reported by a health professional (non-physician/pharmacist) from Spain on 2012-07-05

Patient: 10 year old female

Reactions: Cushingoid, Abdominal Pain, Coagulopathy, Hyponatraemia, Hyperviscosity Syndrome, Headache, Pallor, Somnolence, Hepatic Enzyme Increased, Malaise, Nervous System Disorder, Oedema, Asthenia, Hypertriglyceridaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone Sodium Phosphate
    Dosage: 8 mg/m2, per day
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: 30 mg, unk
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Dosage: 10000 iu/m2, per day
    Indication: Acute Lymphocytic Leukaemia

Prednisone
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Epirubicin; Methotrexate; Cytarabine; Daunorubicin HCL; Methotrexate W / Cytarabine / Hydrocortisone; Vincristine; Cyclophosphamide; Mercaptopurine



Possible Hydrocortisone side effects in 13 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-23

Patient: 13 year old male

Reactions: Klebsiella Infection, Abdominal Pain, Diarrhoea, Fungal Infection, Blood Culture Positive, Bacterial Infection, Aplasia, Candidiasis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Methotrexate
    Dosage: intradiscal (intraspinal)
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-09
    End date: 2011-10-03

Hydrocortisone
    Dosage: intradiscal (intraspinal)
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-20
    End date: 2011-10-03

Cerubidine
    Dosage: intravenous (not otherwise specified)
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-16
    End date: 2011-09-30

Vincristine Sulfate
    Dosage: in accordance with the cycle,intravenous (not otherwise specified)
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-16
    End date: 2011-09-30

Cytarabine
    Dosage: intradiscal (intraspinal)
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-20
    End date: 2011-10-03

(Kidrolase)
    Dosage: intravenous (not otherwise specified)
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-20
    End date: 2011-10-03

Other drugs received by patient: Bactrim; (Amiklin / 00391001 / ); Tazobactam; Solupred / 00016217 / ); Fasturtec



Possible Hydrocortisone side effects in 18 year old male

Reported by a physician from United States on 2012-05-10

Patient: 18 year old male, weighing 126.4 kg (278.1 pounds)

Reactions: Abdominal Pain, White Blood Cell Count Decreased, Hypotension, Hyponatraemia, Acidosis, Capillary Leak Syndrome, Sepsis, Platelet Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Pegaspargase
    Dosage: 2500 iu, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-25
    End date: 2012-03-02

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Vincristine
    Dosage: 2 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Prednisone TAB
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-04

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia

Cytarabine
    Dosage: 70 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-24



Possible Hydrocortisone side effects in male

Reported by a physician from United States on 2012-04-30

Patient: male

Reactions: Abdominal Pain, Vomiting, Nausea, Flatulence, Rash, Mucosal Inflammation, Dysgeusia, Fatigue, Hepatotoxicity, Diarrhoea, Dizziness, Decreased Appetite

Drug(s) suspected as cause:
Hydrocortisone
    Indication: Prostate Cancer Metastatic

Ketoconazole
    Administration route: Oral
    Indication: Prostate Cancer Metastatic

Other drugs received by patient: Gonadotropin-Releasing Hormone Agonist



Possible Hydrocortisone side effects in 18 year old male

Reported by a consumer/non-health professional from United States on 2012-04-13

Patient: 18 year old male, weighing 126.4 kg (278.1 pounds)

Reactions: Abdominal Pain, White Blood Cell Count Decreased, Hypotension, Hyponatraemia, Acidosis, Capillary Leak Syndrome, Sepsis, Platelet Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Vincristine
    Dosage: 2 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Prednisone TAB
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-04

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia

Pegaspargase
    Dosage: 2500 iu, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-25
    End date: 2012-03-02

Cytarabine
    Dosage: 70 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-24

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia



Possible Hydrocortisone side effects in 10 year old female

Reported by a physician from United States on 2012-04-05

Patient: 10 year old female, weighing 20.8 kg (45.8 pounds)

Reactions: Abdominal Pain, Headache, Caecitis, Hypokalaemia, Fungaemia, Hypoxia, Rash Pustular, Back Pain, Nausea, Pain in Extremity, Hypotension, Hyponatraemia, Febrile Neutropenia, Hypophosphataemia, Respiratory Tract Infection, Neuralgia, Enterocolitis Infectious

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisone
    Dosage: 20 mg/m2, cyclic
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-27

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-14

Cytarabine
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Pegaspargase
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-15
    End date: 2011-12-29

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-29

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-17

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29



Possible Hydrocortisone side effects in 18 year old male

Reported by a physician from United States on 2012-04-03

Patient: 18 year old male, weighing 126.4 kg (278.1 pounds)

Reactions: White Blood Cell Count Decreased, Abdominal Pain, Metabolic Acidosis, Clostridium Test Positive, Urine Output Decreased, Hypotension, Hyponatraemia, Capillary Leak Syndrome, Platelet Count Decreased, Septic Shock

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Oncaspar
    Dosage: 2500 iu;x1;iv
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Doxorubicin HCL
    Dosage: 60 mg/m**2;x1;iv
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-24

Velcade
    Dosage: 1.3 mg/m**2; qd; iv
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Vincristine
    Dosage: 1.5 mg/m**2;qd;iv
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Prednisone TAB
    Dosage: 20 mg/m**2;qd;po
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-04

Cytarabine
    Dosage: 70 mg;x1;inth
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: inth
    Indication: Acute Lymphocytic Leukaemia



Possible Hydrocortisone side effects in 10 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-29

Patient: 10 year old female, weighing 20.9 kg (46.0 pounds)

Reactions: Abdominal Pain, Pain in Extremity, Pain, Hypoxia, Cerebrovascular Accident

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fentanyl
    Indication: Pain

Mercaptopurine
    Indication: Product Used FOR Unknown Indication

Hydrocortisone
    Dosage: unk mg, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-17
    End date: 2012-02-17

Methadone HCL
    Indication: Pain

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-17
    End date: 2012-02-24

Cyclophosphamide
    Dosage: 440 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-17
    End date: 2012-02-21

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-17
    End date: 2012-02-21

Methotrexate
    Dosage: unk mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-17
    End date: 2012-02-17

Cytarabine
    Dosage: unk mg, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-17
    End date: 2012-02-17



Possible Hydrocortisone side effects in 18 year old male

Reported by a consumer/non-health professional from United States on 2012-03-13

Patient: 18 year old male, weighing 126.4 kg (278.1 pounds)

Reactions: Abdominal Pain, White Blood Cell Count Decreased, Hypotension, Hyponatraemia, Acidosis, Capillary Leak Syndrome, Sepsis, Platelet Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-24

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Cytarabine
    Dosage: 70 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24

Pegaspargase
    Dosage: 2500 iu, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia

Prednisone TAB
    Dosage: 20 mg/m2, cyclic
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-04

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia



Possible Hydrocortisone side effects in 10 year old female

Reported by a consumer/non-health professional from United States on 2012-03-09

Patient: 10 year old female, weighing 20.8 kg (45.8 pounds)

Reactions: Abdominal Pain, Confusional State, Lung Infection, Headache, Peripheral Sensory Neuropathy, Caecitis, Hypokalaemia, Fungaemia, Hypoxia, Clostridial Infection, Back Pain, Rash Pustular, Vomiting, Nausea, Pain in Extremity, Lung Neoplasm, Hypotension, Febrile Neutropenia, Pancytopenia, Hyponatraemia, Hypophosphataemia, Diarrhoea, NO Therapeutic Response, Sepsis, Hypophagia, Respiratory Tract Infection, Enterocolitis Infectious, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegaspargase
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-15
    End date: 2011-12-29

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-14

Prednisone
    Dosage: 20 mg/m2, cyclic
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-27

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-29

Cytarabine
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-17



Possible Hydrocortisone side effects in male

Reported by a physician from United States on 2012-03-07

Patient: male

Reactions: Abdominal Pain, Vomiting, Nausea, Flatulence, Rash, Dysgeusia, Mucosal Inflammation, Fatigue, Hepatotoxicity, Diarrhoea, Dizziness, Decreased Appetite

Drug(s) suspected as cause:
Hydrocortisone
    Indication: Prostate Cancer Metastatic

Ketoconazole
    Administration route: Oral
    Indication: Prostate Cancer Metastatic

Other drugs received by patient: Gonadotropin-Releasing Hormone Agonist



Possible Hydrocortisone side effects in 10 year old female

Reported by a physician from United States on 2012-01-24

Patient: 10 year old female, weighing 20.8 kg (45.8 pounds)

Reactions: Back Pain, Rash Pustular, Abdominal Pain, Nausea, Pain in Extremity, Hypotension, Hyponatraemia, Febrile Neutropenia, Headache, Peripheral Sensory Neuropathy, Caecitis, Hypokalaemia, Hypophosphataemia, Fungaemia, Hypoxia, Respiratory Tract Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-17

Prednisone TAB
    Dosage: 20 mg/m2, cyclic
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-27

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-29

Pegaspargase
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-15
    End date: 2011-12-29

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-14

Cytarabine
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29



Possible Hydrocortisone side effects in 72 year old female

Reported by a consumer/non-health professional from United States on 2011-11-09

Patient: 72 year old female, weighing 81.6 kg (179.6 pounds)

Reactions: Irritability, Burning Sensation, Abdominal Pain, Nausea, Pain

Drug(s) suspected as cause:
Hydrocortisone



Possible Hydrocortisone side effects in female

Reported by a physician from Canada on 2011-11-02

Patient: female, weighing 97.6 kg (214.7 pounds)

Reactions: Abdominal Pain, Fistula, Drug Ineffective, Crohn's Disease, Pain, Gastrointestinal Inflammation, Drug Dependence, Abscess Intestinal

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Humira
    Start date: 2011-06-07
    End date: 2011-09-06

Hydrocortisone
    Administration route: Oral
    Indication: Abscess Intestinal
    Start date: 2011-05-06

Hydrocortisone
    Indication: Inflammation

Humira
    Indication: Crohn's Disease
    Start date: 2009-08-11
    End date: 2011-06-07

Humira
    Start date: 2011-05-16
    End date: 2011-06-01

Other drugs received by patient: Calcium with Vitamin D; Elavil



Possible Hydrocortisone side effects in 11 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-10-28

Patient: 11 year old female, weighing 35.0 kg (77.0 pounds)

Reactions: Abdominal Pain, Hepatic Function Abnormal, Hypersensitivity, Pain, Rectal Haemorrhage, Extrasystoles, Coagulopathy, Headache, Skin Hyperpigmentation, Caecitis, Erythema, Multi-Organ Failure, Dyspepsia, Chest Pain, Renal Failure Acute, Heart Rate Abnormal, Anuria, Pain in Extremity, Hypotension, Musculoskeletal Pain, Atrial Fibrillation, Rash, Arrhythmia, Acute Lymphocytic Leukaemia, Mucosal Inflammation, Oral Pain, Respiratory Failure, Rash Erythematous, Heart Rate Increased, Electrocardiogram P Wave Abnormal

Adverse event resulted in: death

Drug(s) suspected as cause:
Evoltra
    Dosage: 48 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-06-17
    End date: 2011-06-21

Dexamethasone
    Dosage: 6 mg, bid
    Administration route: Oral
    Start date: 2011-05-26
    End date: 2011-06-08

Dexamethasone
    Dosage: 6 mg, bid
    Administration route: Oral
    Start date: 2011-06-17
    End date: 2011-06-23

Cytarabine
    Dosage: 30 mg, 1x/w
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-05-11
    End date: 2011-06-08

Methotrexate
    Dosage: 12 mg, 1x/w
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-05-11
    End date: 2011-06-22

Etoposide
    Dosage: 120 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-05-12
    End date: 2011-05-16

PEG-Asparaginase
    Dosage: 1200 iu, q2w
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-05-12
    End date: 2011-05-26

Hydrocortisone
    Dosage: 12.5 mg, 1x/w
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-05-11
    End date: 2011-06-08

Vincristine
    Dosage: 1.7 mg, 1x/w
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-05-12
    End date: 2011-06-02

Cyclophosphamide
    Dosage: 360 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-06-17
    End date: 2011-06-21

Dexamethasone
    Dosage: 6 mg, bid
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-05-12
    End date: 2011-05-18

Etoposide
    Dosage: 120 mg, qd
    Start date: 2011-06-17
    End date: 2011-06-21

Dexamethasone
    Dosage: 6 mg, bid
    Administration route: Oral
    Start date: 2011-07-01
    End date: 2011-07-07

Other drugs received by patient: Allopurinol; Cotrim; Levomepromazine; Piperacillin W; Acetaminophen; Ambisome; Acetaminophen; Allopurinol; Ondansetron; Ciprofloxacin; Levomepromazine; Omeprazole; Ondansetron; Penicillin V; Cotrim; Metronidazole

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017